The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37
Open accessAbstract
The influence of ion composition, pH, and peptide concentration on the conformation and activity of the 37-residue human antibacterial peptide LL-37 has been studied. At micromolar concentration in water, LL-37 exhibits a circular dichroism spectrum consistent with a disordered structure. The addition of 15 mM HCO3-, SO42-, or CF3CO2- causes the peptide to adopt a helical structure, with approximately equal efficiency, while 160 mM Cl- is less efficient. A cooperative transition from disordered to helical structure is observed as the peptide concentration is increased, consistent with formation of an oligomer. The extent of alpha-helicity correlates with the antibacterial activity of LL-37 against both Gram-positive and Gram-negative bacteria. Two homologous peptides, FF-33 and SK-29, containing 4 and 8 residue deletions at the N terminus, respectively, require higher concentrations of anions for helix formation and are less active than LL-37 against Escherichia coli D21. Below pH 5, the helical content of LL-37 gradually decreases, and at pH 2 it is entirely disordered. In contrast, the helical structure is retained at pH over 13. The minimal inhibitory concentration of LL-37 against E. coli is 5 microM, and at 13-25 microM the peptide is cytotoxic against several eukaryotic cells. In solutions containing the ion compositions of plasma, intracellular fluid, or interstitial fluid, LL-37 is helical, and hence it could pose a danger to human cells upon release. However, in the presence of human serum, the antibacterial and the cytotoxic activities of LL-37 are inhibited.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ACETYLORNITHINASE OF ESCHERICHIA COLI: PARTIAL PURIFICATION AND SOME PROPERTIES
Vogel, H. J., & Bonner, D. M. (1956) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65874-0 · Cited by 3,991
Computed circular dichroism spectra for the evaluation of protein conformation
Greenfield, N. J., & Fasman, G. D. (1969) · Biochemistry · doi:10.1021/bi00838a031 · Cited by 3,694
Proteins: Structures and Molecular Properties
Creighton, T. E. (1986) · Medical Entomology and Zoology · Cited by 2,645
Peptide Antibiotics and Their Role in Innate Immunity
Boman, H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.61 · Cited by 1,665
How Hofmeister ion interactions affect protein stability
Baldwin, R. L. (1996) · Biophysical Journal · doi:10.1016/s0006-3495(96)79404-3 · Cited by 1,124
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Merrifield, B. (1986) · Science · doi:10.1126/science.3961484 · Cited by 1,005
Defensins: Antimicrobial and Cytotoxic Peptides of Mammalian Cells
Lehrer, R. I., Lichtenstein, A. K., & Ganz, T. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.000541 · Cited by 991
Helix stabilization by Glu-...Lys+ salt bridges in short peptides of de novo design.
Marqusee, S., & Baldwin, R. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.8898 · Cited by 952
Protein secondary structure and circular dichroism: A practical guide
Johnson, W. C. (1990) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340070302 · Cited by 940
Cited by
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Shai, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00200-x · Cited by 1,869
Natively unfolded proteins: A point where biology waits for physics
Uversky, V. N. (2002) · Protein Science · doi:10.1110/ps.4210102 · Cited by 1,813
Mode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
Lai, Y., & Gallo, R. L. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.12.003 · Cited by 1,276
Yang, D., Chen, Q., Schmidt, A. P., Anderson, G. M., Wang, J. M., Wooters, J., Oppenheim, J. J., & Chertov, O. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1069 · Cited by 1,240
Antimicrobial peptides: mechanism of action, activity and clinical potential
Zhang, Q.-Y., Yan, Z.-B., Meng, Y.-M., Hong, X.-Y., Shao, G., Ma, J.-J., Cheng, X.-R., Liu, J., Kang, J., & Fu, C.-Y. (2021) · Military Medical Research · doi:10.1186/s40779-021-00343-2 · Cited by 1,065
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Cathelicidins, multifunctional peptides of the innate immunity
Zanetti, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403147 · Cited by 988
What does it mean to be natively unfolded?
Uversky, V. N. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02649.x · Cited by 982
Sørensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Tjabringa, G. S., Hiemstra, P. S., & Borregaard, N. (2001) · Blood · doi:10.1182/blood.v97.12.3951 · Cited by 894
Application of natural antimicrobials for food preservation
Tiwari, B. K., Valdramidis, V. P., O’ Donnell, C. P., Muthukumarappan, K., Bourke, P., & Cullen, P. J. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf900668n · Cited by 851
Mode of action of linear amphipathic α-helical antimicrobial peptides
Oren, Z., & Shai, Y. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(1998)47:6<451::aid-bip4>3.0.co;2-f · Cited by 848
Antimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 799
Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jörnvall, H., Wigzell, H., & Gudmundsson, G. H. (2000) · Blood · doi:10.1182/blood.v96.9.3086 · Cited by 758
Self-citationAntimicrobial peptides in mammalian and insect host defence
Lehrer, R. I., & Ganz, T. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80005-3 · Cited by 723
Chromek, M., Slamová, Z., Bergman, P., Kovács, L., Podracká, L., Ehrén, I., Hökfelt, T., Gudmundsson, G. H., Gallo, R. L., Agerberth, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1407 · Cited by 652
Self-citationAnimal antimicrobial peptides: An overview
Andreu, D., & Rivas, L. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(1998)47:6<415::aid-bip2>3.0.co;2-d · Cited by 618
Multifunctional cationic host defence peptides and their clinical applications
Yeung, A. T. Y., Gellatly, S. L., & Hancock, R. E. W. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0710-x · Cited by 610
Heilborn, J. D., Nilsson, M. F., Sørensen, O., Ståhle-Bäckdahl, M., Kratz, G., Weber, G., & Borregaard, N. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12069.x · Cited by 572
Dorschner, R. A., Pestonjamasp, V. K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G. H., & Gallo, R. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01340.x · Cited by 567
Self-citationUnusual biophysics of intrinsically disordered proteins
Uversky, V. N. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.12.008 · Cited by 566
Intrinsically Disordered Proteins and Their “Mysterious” (Meta)Physics
Uversky, V. N. (2019) · Frontiers in Physics · doi:10.3389/fphy.2019.00010 · Cited by 532
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
Host defense peptides as new weapons in cancer treatment
Papo, N., & Shai, Y. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4560-2 · Cited by 501
A decade and a half of protein intrinsic disorder: Biology still waits for physics
Uversky, V. N. (2013) · Protein Science · doi:10.1002/pro.2261 · Cited by 499
Wang, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805533200 · Cited by 482
The antimicrobial protection hypothesis of Alzheimer’s disease
Moir, R. D., Lathe, R., & Tanzi, R. E. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.06.3040 · Cited by 456
Assessing protein disorder and induced folding
Receveur‐Bréchot, V., Bourhis, J., Uversky, V. N., Canard, B., & Longhi, S. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20750 · Cited by 445
Zelezetsky, I., & Tossi, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.021 · Cited by 439
Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs)
Dijksteel, G. S., Ulrich, M. M. W., Middelkoop, E., & Boekema, B. K. H. L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.616979 · Cited by 428
Elssner, A., Duncan, M., Gavrilin, M., & Wewers, M. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4987 · Cited by 425
Schwalfenberg, G. K. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000174 · Cited by 414
The Role of Cathelicidins in the Innate Host Defenses of Mammals
(2005) · Current Issues in Molecular Biology · doi:10.21775/cimb.007.179 · Cited by 393
Schauber, J. (2003) · Gut · doi:10.1136/gut.52.5.735 · Cited by 383
From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides
Shai, Y., & Oren, Z. (2001) · Peptides · doi:10.1016/s0196-9781(01)00498-3 · Cited by 370
Bactericidal Activity of Mammalian Cathelicidin-Derived Peptides
Travis, S. M., Anderson, N. N., Forsyth, W. R., Espiritu, C., Conway, B. D., Greenberg, E. P., McCray, P. B., Lehrer, R. I., Welsh, M. J., & Tack, B. F. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2748-2755.2000 · Cited by 369
The human cathelicidin LL-37 — A pore-forming antibacterial peptide and host-cell modulator
Xhindoli, D., Pacor, S., Benincasa, M., Scocchi, M., Gennaro, R., & Tossi, A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.11.003 · Cited by 366
Uversky, V. N. (2009) · The Protein Journal · doi:10.1007/s10930-009-9201-4 · Cited by 360
Tokumaru, S., Sayama, K., Shirakata, Y., Komatsuzawa, H., Ouhara, K., Hanakawa, Y., Yahata, Y., Dai, X., Tohyama, M., Nagai, H., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4662 · Cited by 358
Frohm Nilsson, M., Sandstedt, B., Sørensen, O., Weber, G., Borregaard, N., & Ståhle-Bäckdahl, M. (1999) · Infection and Immunity · doi:10.1128/iai.67.5.2561-2566.1999 · Cited by 351
Membrane targeting cationic antimicrobial peptides
Ciumac, D., Gong, H., Hu, X., & Lu, J. R. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.10.103 · Cited by 351
Papo, N., & Shai, Y. (2003) · Peptides · doi:10.1016/j.peptides.2003.09.013 · Cited by 298
Perturbation of the Hydrophobic Core of Lipid Bilayers by the Human Antimicrobial Peptide LL-37
Henzler-Wildman, K. A., Martinez, G. V., Brown, M. F., & Ramamoorthy, A. (2004) · Biochemistry · doi:10.1021/bi036284s · Cited by 296
Basis for Selectivity of Cationic Antimicrobial Peptides for Bacterial Versus Mammalian Membranes
Glukhov, E., Stark, M., Burrows, L. L., & Deber, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507042200 · Cited by 294
Hase, K., Eckmann, L., Leopard, J. D., Varki, N., & Kagnoff, M. F. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.953-963.2002 · Cited by 293
Cathelicidin Anti-Microbial Peptide Expression in Sweat, an Innate Defense System for the Skin
Murakami, M., Ohtake, T., Dorschner, R. A., Gallo, R. L., Schittek, B., & Garbe, C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.19507.x · Cited by 291
Structural features and biological activities of the cathelicidin-derived antimicrobial peptides
Gennaro, R., & Zanetti, M. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<31::aid-bip40>3.0.co;2-9 · Cited by 291
The roles of cathelicidin LL-37 in immune defences and novel clinical applications
Nijnik, A., & Hancock, R. E. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32831ac517 · Cited by 287
Mechanistic Landscape of Membrane-Permeabilizing Peptides
Guha, S., Ghimire, J., Wu, E., & Wimley, W. C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00520 · Cited by 280
Yang, D., Chertov, O., & Oppenheim, J. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.5.691 · Cited by 279
Antimicrobial peptides: natural effectors of the innate immune system
Radek, K., & Gallo, R. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0064-5 · Cited by 275
Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity
Ramanathan, B., Davis, E. G., Ross, C. R., & Blecha, F. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01549-6 · Cited by 268
Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37
Sochacki, K. A., Barns, K. J., Bucki, R., & Weisshaar, J. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101130108 · Cited by 267
Cathelicidins: Immunomodulatory Antimicrobials
Van Harten, R. M., Van Woudenbergh, E., Van Dijk, A., & Haagsman, H. P. (2018) · Vaccines · doi:10.3390/vaccines6030063 · Cited by 258
Mowery, B. P., Lindner, A. H., Weisblum, B., Stahl, S. S., & Gellman, S. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901613g · Cited by 257
Antimicrobial peptides important in innate immunity
Cederlund, A., Gudmundsson, G. H., & Agerberth, B. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08302.x · Cited by 256
Self-citationAntimicrobial skin peptides and proteins
Schröder, J. M., & Harder, J. (2006) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5364-0 · Cited by 253
Wang, G., Mishra, B., Epand, R. F., & Epand, R. M. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.01.016 · Cited by 184
Sonawane, A., Santos, J. C., Mishra, B. B., Jena, P., Progida, C., Sorensen, O. E., Gallo, R., Appelberg, R., & Griffiths, G. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01644.x · Cited by 165
Zhou, Y., Shi, Y., Yang, L., Sun, Y., Han, Y., Zhao, Z., Wang, Y., Liu, Y., Ma, Y., Zhang, T., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201810233 · Cited by 37
Metadata
- Authors
- Johansson, J., Gudmundsson, G. H., Rottenberg, M. E., Berndt, K. D., & Agerberth, B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-02
- Volume
- 273
- Issue
- 6
- Pages
- 3718-3724
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1971642218
- Cited by
- 661
- References
- 35
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.